Get Them High On Your Supply: More Cannabis Retail and Supply Agreements

POINT ROBERTS, Wash. and DELTA, B.C., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the new supply and retail opportunities opening up in the cannabis sector with more relaxed legislation and outside industry support.

As legislation and public perception continue to change surrounding the cannabis sector, particularly hemp, we see more and more retail and supply chain agreements coming to the sector in 2019; many in new areas with new partners to the industry.

It’s a big week for cannabis stocks, with some of the leaders reporting earnings and major deals being announced - showcasing how significant this sector is becoming. 

Making sure to strike while the iron is hot for cannabis, Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) announced yesterday that it has entered into an agreement with Simon Property Group, Inc. (NYSE: SPG), giving GGB access to 108 prime shop locations in US malls owned and operated by Simon. GGB will further expand its chain of CBD-infused personal care product shops under the Seventh Sense botanical therapy brand and other GGB brands.

"Our partnership with Simon allows GGB to launch our brands and CBD products in premier shopping destinations across the US," said Peter Horvath, CEO of GGB. "Our management team has had decades of experience working closely with developers and operating premium retail stores in their properties. We know this arrangement gives us access to the best locations, foot traffic, and consumers. We look forward to introducing our remarkable retail experience and line of CBD products to Simon shoppers in the near future."

Simon is the largest shopping mall operator in the United States¹, and its high-profile properties include Roosevelt Field in metro New York; The Galleria in Houston, TX; and Woodbury Common Premium Outlets in Central Valley, NY. The expansive nature of the relationship with Simon makes it the first of its kind in the CBD industry and will give GGB access to entire markets of new customers at many of the nation's most productive retail locations.

GGB Beauty also recently announced a licensing agreement with Authentic Brands Group to develop a line of CBD infused personal care products.  The Company will be working with Tilray Inc. (NASDAQ: TLRY) as the preferred supplier of the CBD ingredients to be used in these products.

Tilray also recently entered into a marketing agreement with Authentic Brands Group to market and distribute a portfolio of consumer cannabis products within Authentic’s brand portfolio, in jurisdictions where regulations permit.

Tilray, Inc. is expected to release fourth-quarter 2018 results February 12^th at the close. In the last reported quarter, Tilray beat earnings expectations by 42.9% after going public in July 2018.

Aurora beat earnings estimates reporting on its financials for the second quarter ended December 31, 2018. The report was positive with a net revenue of $54.2 million, up 83% sequentially, and up 363% compared to the same period in 2018, driven by Aurora's strong performance in the launch of the Canadian consumer market with sales of $21.6 million, and the Company's continued strength in the Canadian and international medical markets with sales of $26.0 million, up 8% in revenue and 23% in volume sold.

Aurora Cannabis Inc.(NYSE:ACB) (TSX:ACB.TO) has been strategically expanding its international footprint from day one, and the company has now announced that it completed its first commercial export of cannabis oil to the United Kingdom and the product has been successfully dispensed from a pharmacy.

Competitor company, Canopy Growth (NYSE: CGC) (TSX: WEED.TO) is also expected to release their quarterly results this week on Thursday, Feb 14th.  Canopy made headlines in mid-January with news that it had been granted a license by New York State to process and produce hemp.

Canopy says it will establish within the Hemp Industrial Park, large-scale production capabilities focused on hemp extraction and product manufacturing within the United States.

They also said, “Depending on Board approval of a specific site, Canopy Growth intends to invest between $100 million USD and $150 million USD in its New York operations, capable of producing tons of hemp extract on an annual basis.”